Simultaneously, analyzing the role of p53 in Gemcitabine-mediated cytotoxicity and in the radiosensitization of RKO cells of colon cancer, the study demonstrated that p53 could be a mediator of Gemcitabine sensitivity, but the effect is considered minor. The gene discussed is TP53; the disease is colonic neoplasm.